| Business Summary | | IVAX
Diagnostics,
Inc.
develops,
manufactures,
and
markets
diagnostic
test
kits
or
assays
that
are
used
to
aid
in
the
detection
of
disease
markers
primarily
in
the
areas
of
autoimmune
and
infectious
diseases.
These
tests,
which
are
designed
to
aid
in
the
identification
of
the
causes
of
illness
and
disease,
assist
physicians
in
selecting
appropriate
patient
treatment.
Most
of
IVAX
Diagnostics'
tests
are
based
on
Enzyme
Linked
ImmunoSorbent
Assay
technology,
a
clinical
testing
methodology
used
worldwide.
IVAX
Diagnostics'
kits
are
designed
to
be
performed
either
manually
or
in
an
automated
format.
In
addition
to
an
extensive
line
of
diagnostic
kits,
IVAX
Diagnostics
designs
and
manufactures
laboratory
instruments
that
perform
the
tests
and
provide
fast
and
accurate
results,
while
reducing
labor
costs.
IVAX
Diagnostics
also
develops,
manufactures,
and
markets
raw
materials,
such
as
antigens
used
in
the
production
of
diagnostic
kits. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | IVD
is
engaged
in
developing,
manufacturing
and
marketing
of
diagnostic
test
kits,
reagents
and
instruments
for
use
in
hospital
and
reference
laboratories
and
doctors'
offices.
For
the
six
months
ended
6/30/01,
net
revenues
decreased
8%
to
$6.6
million.
Net
loss
totaled
$1.5
million,
up
from
$283
thousand.
Revenues
reflect
decreased
sales
volumes
of
instrumentation
products.
Net
loss
also
reflects
the
inclusion
of
a
$1.3
million
merger-related
expense. | More
from
Market Guide: Significant
Developments |
| | | | FY1999 Pay | |
| Giorgio D'Urso, 65 Pres,
CEO | $485K | Mark Deutsch, 38 CFO,
VP-Fin. | -- | Raul Alvarez VP, Sales and Marketing - International | -- | Duane Steele, 50 VP-Bus.
Devel. | 128K | Dollar amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|